サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1428150

総合代謝パネル（CMP）検査の世界市場レポート 2024

Comprehensive Metabolic Panel (CMP) Testing Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
総合代謝パネル（CMP）検査の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

総合代謝パネル（CMP）検査の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には8.3%の年間平均成長率（CAGR）で232億8,000万米ドルに成長すると予想されます。予測期間で予想される成長は、個別化医療と精密ヘルスケアの重視の高まり、遠隔医療サービスへの総合代謝パネル（CMP）検査の統合、包括的な健康診断の需要の高まり、ウェルネスと予防健康への取り組みの高まり、ヘルスケア政策と規制の継続的な進化などに起因すると考えられます。この期間に予想される主な動向には、健康パラメータの継続的なモニタリングと長期的な追跡、遠隔医療との互換性を考慮したレポート形式、比較可能性を高めるための参照範囲の標準化、データ収集のためのウェアラブル医療技術の統合、ヘルスケアエコシステムによる、患者教育と患者への関与の強化が含まれます。

心血管疾患と糖尿病の有病率の予想される増加は、総合代謝パネル（CMP）検査市場の成長の原動力になると予想されます。心臓や血管に影響を与える心血管疾患は、多くの場合、動脈内の脂肪沈着物の蓄積であるアテローム性動脈硬化症と関連しています。同時に、血糖値の上昇を特徴とする糖尿病は、総合代謝パネル（CMP）血液検査によって特定できます。糖尿病や心血管疾患の症例が増加するにつれ、CMP血液検査を含む診断用血液検査の需要が急増する可能性があります。たとえば、オーストラリア保健福祉研究所が提供した2023年12月のデータは、冠状動脈性心疾患（CHD）が原因と医師が認定した死亡者数が増加傾向にあり、2022年には14,900人に達することを示しています。さらに、2022年6月に国際糖尿病連盟は報告によると、世界の糖尿病有病率は10.5%で、かなりの部分（44.7%）が未診断のままです。したがって、心血管疾患と糖尿病の発生率の増加が、総合代謝パネル（CMP）検査市場を推進する重要な原動力となっています。

高齢者人口の増加は、近い将来、総合代謝パネル（CMP）検査市場の拡大に大きく寄与すると予想されます。「高齢者集団」という用語は、健康状態を監視し、加齢に伴う健康上の問題に対処するために、より頻繁な健康診断を必要とする65歳以上の高齢者を指します。代謝パネル検査は、この人口統計において極めて重要となっており、高齢者の腎臓病、ホルモンの不均衡、糖尿病などの基礎疾患を検出するツールとして機能します。 2022年 11月、アメリカの健康ランキングは、2021年には米国の65歳以上の人口が5,580万人を超え、総人口の約16.8%を占めると予測されると報告しました。この人口統計が成長し続けるにつれて、総合代謝パネル（CMP）検査の需要が増加すると予想され、高齢者人口が総合代謝パネル（CMP）検査市場の主要な推進力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の総合代謝パネル（CMP）検査市場促進要因と制約要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の総合代謝パネル（CMP）検査の市場規模実績と成長、2018～2023年
  • 世界の総合代謝パネル（CMP）検査市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の総合代謝パネル（CMP）検査市場、疾患別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 腎臓病
  • 肝疾患
  • 糖尿病
  • その他の病気
  • 世界の総合代謝パネル（CMP）検査市場、検査タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • タンパク質
  • 電解質
  • 腎臓検査
  • 肝機能検査
  • グルコース
  • 世界の総合代謝パネル（CMP）検査市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 研究室
  • ポイントオブケア（PoC）

第7章 地域および国の分析

  • 世界の総合代謝パネル（CMP）検査市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の総合代謝パネル（CMP）検査市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 総合代謝パネル（CMP）検査市場の競合情勢
  • 総合代謝パネル（CMP）検査市場の企業プロファイル
    • F Hoffmann-La Roche Ltd.
    • Abbott Laboratories Inc.
    • Siemens Healthineers AG
    • Mayo Clinic
    • Laboratory Corporation of America Holdings

第31章 その他の大手および革新的な企業

  • Mercy
  • Mount Sinai Health System
  • Quest Diagnostics Incorporated
  • Sonic Healthcare Limited
  • Hologic Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Werfen SA
  • DiaSorin SpA
  • Randox Laboratories Ltd.
  • ARUP Laboratories Inc.
  • Invitae Corporation
  • Abaxis Inc.
  • Metropolis Healthcare Limited
  • Clinical Reference Laboratory（CRL）

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13994

A comprehensive metabolic panel (CMP) test is a blood analysis consisting of 14 distinct parameters that provide crucial insights into the body's chemical balance and metabolic processes. This test serves as a vital tool for evaluating nutritional levels, liver and kidney functionality, and aids in diagnosing, screening, and monitoring various health conditions.

The primary diseases and health conditions assessed through comprehensive metabolic panel (CMP) testing include kidney disease, liver disease, diabetes, and other metabolic disorders. Kidney disease is characterized by impaired kidney function, affecting its ability to effectively filter blood and perform essential functions. The test encompasses evaluations of proteins, electrolytes, kidney function, liver function, and glucose levels, conducted in both laboratory settings and point-of-care (PoC) environments.

The comprehensive metabolic panel (CMP) testing market research report is one of a series of new reports from The Business Research Company that provides comprehensive metabolic panel (CMP) testing market statistics, including comprehensive metabolic panel (CMP) testing industry global market size, regional shares, competitors with a comprehensive metabolic panel (CMP) testing market share, detailed comprehensive metabolic panel (CMP) testing market segments, market trends and opportunities, and any further data you may need to thrive in the comprehensive metabolic panel (CMP) testing industry. This comprehensive metabolic panel (CMP) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The comprehensive metabolic panel (cmp) testing market size has grown strongly in recent years. It will grow from $15.61 billion in 2023 to $16.94 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The growth observed in the historic period can be attributed to several factors, including an increase in chronic diseases, a growing demand for comprehensive health assessments, a shift within healthcare systems towards preventive care, a rise in conditions related to lifestyle factors, and an emphasis on patient-centric healthcare approaches. These factors collectively contributed to the expansion and evolution of healthcare services and practices during that period.

The comprehensive metabolic panel (cmp) testing market size is expected to see strong growth in the next few years. It will grow to $23.28 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing emphasis on personalized medicine and precision healthcare, the integration of Comprehensive Metabolic Panel (CMP) testing within telehealth services, a growing demand for comprehensive health screenings, an upsurge in wellness and preventive health initiatives, and ongoing evolution in healthcare policies and regulations. Major trends expected in this period encompass continuous monitoring and longitudinal tracking of health parameters, reporting formats tailored for telemedicine compatibility, standardization of reference ranges for better comparability, integration of wearable health technology for data collection, and a heightened focus on patient education and engagement within the healthcare ecosystem.

The anticipated rise in the prevalence of cardiovascular diseases and diabetes is expected to be a driving force behind the growth of the comprehensive metabolic panel (CMP) testing market. Cardiovascular diseases, which affect the heart and blood vessels, are often associated with atherosclerosis-the accumulation of fatty deposits within arteries. Concurrently, diabetes, characterized by elevated blood glucose levels, can be identified through comprehensive metabolic panel (CMP) blood tests. As cases of diabetes and cardiovascular diseases increase, the demand for diagnostic blood tests, including the CMP blood test, is likely to surge. For instance, data from December 2023 provided by the Australian Institute of Health and Welfare indicated a rising trend in doctor-certified fatalities attributed to coronary heart disease (CHD), reaching 14,900 in 2022. Additionally, in June 2022, the International Diabetes Federation reported a global diabetes prevalence of 10.5%, with a significant portion (44.7%) of individuals remaining undiagnosed. Consequently, the growing incidence of cardiovascular diseases and diabetes is a key driver propelling the comprehensive metabolic panel (CMP) testing market.

The increasing geriatric population is anticipated to contribute significantly to the expansion of the comprehensive metabolic panel (CMP) testing market in the foreseeable future. The term 'geriatric population' refers to individuals who are elderly, typically aged 65 or older, requiring more frequent health tests to monitor their well-being and address age-related health issues. Metabolic panel testing becomes crucial in this demographic, serving as a tool to detect underlying conditions such as kidney diseases, hormonal imbalances, and diabetes in older adults. In November 2022, America's Health Rankings reported that the United States is projected to have more than 55.8 million individuals aged 65 and above in 2021, accounting for approximately 16.8% of the total population. As this demographic continues to grow, the demand for comprehensive metabolic panel (CMP) testing is expected to rise, making the geriatric population a key driver in the comprehensive metabolic panel (CMP) testing market.

The comprehensive metabolic panel (CMP) testing market is witnessing a significant trend of technological advancements, with major companies investing in innovative solutions to fortify their market positions. In April 2022, HealthifyMe, an Indian wellness and fitness services company, introduced HealthifyPro, a flagship fitness plan incorporating a metabolic panel based on a comprehensive blood test measuring over 80 different factors. HealthifyPro utilizes a biosensor system, a smart scale, health coaches, an AI assistant, and a metabolic panel to track users' health. The integration of glucose patterns, dietary habits, and exercise behaviors enables the creation of personalized health approaches for each user, showcasing the role of technology in advancing metabolic panel testing.

Strategic partnerships are a prominent approach adopted by major companies in the comprehensive metabolic panel (CMP) testing market. These partnerships aim to enhance production capabilities, streamline testing processes, and meet the increasing demand for CMP testing across various industries. In August 2022, Abbott Laboratories, a US-based healthcare company, collaborated with WW International Inc., a provider of weight loss and fitness services. The partnership focuses on assisting individuals with diabetes in better understanding and managing their health. By integrating WeightWatchers' diabetes-specific weight management program with Abbott's FreeStyle Libre offerings, the collaboration aims to provide a seamless mobile experience, offering valuable insights for individuals with diabetes to make informed dietary adjustments and improve blood sugar levels, ultimately empowering them to take control of their health.

In March 2023, Fluxery, a medical diagnostic company headquartered in the United States, completed the acquisition of particular personnel, assets, and licensed electrochemical biosensing technologies from InnaMed Inc. The financial details of the transaction remain undisclosed. This strategic acquisition by Fluxery significantly expands its detection capabilities, allowing for the analysis of clinical chemistry and small molecules in various domains, including human healthcare, equine care, and veterinary services for small animals. InnaMed Inc., a decentralized blood testing company in the US, specializes in electrochemical biosensor technology.

Major companies operating in the comprehensive metabolic panel (cmp) testing market report are F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Siemens Healthineers AG, Mayo Clinic, Laboratory Corporation of America Holdings, Mercy, Mount Sinai Health System, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Hologic Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Werfen SA, DiaSorin S.p.A., Randox Laboratories Ltd., ARUP Laboratories Inc., Invitae Corporation, Abaxis Inc., Metropolis Healthcare Limited, Clinical Reference Laboratory (CRL), Centogene AG, Spectra Laboratories, Unipath Systems Ltd., Scion Lab Services LLC, Weldon Biotech Pvt Ltd., Corona Pathology,Ulta Lab Tests LLC, Any Lab Test Now, Applied InGENuity Diagnostics LLC, Walk-In Lab LLC.

North America was the largest region in the comprehensive metabolic panel (CMP) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the comprehensive metabolic panel (cmp) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the comprehensive metabolic panel (cmp) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The comprehensive metabolic panel (CMP) testing market includes revenues earned by entities by providing glucose tests, sodium tests, and albumin tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Comprehensive Metabolic Panel (CMP) Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on comprehensive metabolic panel (cmp) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for comprehensive metabolic panel (cmp) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The comprehensive metabolic panel (cmp) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Disease: Kidney Disease; Liver Disease; Diabetes; Other Diseases
  • 2) By Test Type: Proteins; Electrolytes; Kidney Tests; Liver Functional Tests; Glucose
  • 3) By End User: Laboratories; Point Of Care (PoC)
  • Companies Mentioned: F Hoffmann-La Roche Ltd.; Abbott Laboratories Inc.; Siemens Healthineers AG; Mayo Clinic; Laboratory Corporation of America Holdings
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Comprehensive Metabolic Panel (CMP) Testing Market Characteristics

3. Comprehensive Metabolic Panel (CMP) Testing Market Trends And Strategies

4. Comprehensive Metabolic Panel (CMP) Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Comprehensive Metabolic Panel (CMP) Testing Market Size and Growth

  • 5.1. Global Comprehensive Metabolic Panel (CMP) Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Comprehensive Metabolic Panel (CMP) Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Comprehensive Metabolic Panel (CMP) Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Comprehensive Metabolic Panel (CMP) Testing Market Segmentation

  • 6.1. Global Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Kidney Disease
  • Liver Disease
  • Diabetes
  • Other Diseases
  • 6.2. Global Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Proteins
  • Electrolytes
  • Kidney Tests
  • Liver Functional Tests
  • Glucose
  • 6.3. Global Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Laboratories
  • Point Of Care (PoC)

7. Comprehensive Metabolic Panel (CMP) Testing Market Regional And Country Analysis

  • 7.1. Global Comprehensive Metabolic Panel (CMP) Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Comprehensive Metabolic Panel (CMP) Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market

  • 8.1. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Comprehensive Metabolic Panel (CMP) Testing Market

  • 9.1. China Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 9.2. China Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Comprehensive Metabolic Panel (CMP) Testing Market

  • 10.1. India Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Comprehensive Metabolic Panel (CMP) Testing Market

  • 11.1. Japan Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 11.2. Japan Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Comprehensive Metabolic Panel (CMP) Testing Market

  • 12.1. Australia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Comprehensive Metabolic Panel (CMP) Testing Market

  • 13.1. Indonesia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Comprehensive Metabolic Panel (CMP) Testing Market

  • 14.1. South Korea Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 14.2. South Korea Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market

  • 15.1. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 15.2. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Comprehensive Metabolic Panel (CMP) Testing Market

  • 16.1. UK Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Comprehensive Metabolic Panel (CMP) Testing Market

  • 17.1. Germany Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Comprehensive Metabolic Panel (CMP) Testing Market

  • 18.1. France Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Comprehensive Metabolic Panel (CMP) Testing Market

  • 19.1. Italy Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Comprehensive Metabolic Panel (CMP) Testing Market

  • 20.1. Spain Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market

  • 21.1. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 21.2. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Comprehensive Metabolic Panel (CMP) Testing Market

  • 22.1. Russia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Comprehensive Metabolic Panel (CMP) Testing Market

  • 23.1. North America Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 23.2. North America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Comprehensive Metabolic Panel (CMP) Testing Market

  • 24.1. USA Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 24.2. USA Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Comprehensive Metabolic Panel (CMP) Testing Market

  • 25.1. Canada Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 25.2. Canada Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Comprehensive Metabolic Panel (CMP) Testing Market

  • 26.1. South America Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 26.2. South America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Comprehensive Metabolic Panel (CMP) Testing Market

  • 27.1. Brazil Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Comprehensive Metabolic Panel (CMP) Testing Market

  • 28.1. Middle East Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 28.2. Middle East Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Comprehensive Metabolic Panel (CMP) Testing Market

  • 29.1. Africa Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 29.2. Africa Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Comprehensive Metabolic Panel (CMP) Testing Market Competitive Landscape And Company Profiles

  • 30.1. Comprehensive Metabolic Panel (CMP) Testing Market Competitive Landscape
  • 30.2. Comprehensive Metabolic Panel (CMP) Testing Market Company Profiles
    • 30.2.1. F Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens Healthineers AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Mayo Clinic
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Laboratory Corporation of America Holdings
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Comprehensive Metabolic Panel (CMP) Testing Market Other Major And Innovative Companies

  • 31.1. Mercy
  • 31.2. Mount Sinai Health System
  • 31.3. Quest Diagnostics Incorporated
  • 31.4. Sonic Healthcare Limited
  • 31.5. Hologic Inc.
  • 31.6. Beckman Coulter Inc.
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. Werfen SA
  • 31.9. DiaSorin S.p.A.
  • 31.10. Randox Laboratories Ltd.
  • 31.11. ARUP Laboratories Inc.
  • 31.12. Invitae Corporation
  • 31.13. Abaxis Inc.
  • 31.14. Metropolis Healthcare Limited
  • 31.15. Clinical Reference Laboratory (CRL)

32. Global Comprehensive Metabolic Panel (CMP) Testing Market Competitive Benchmarking

33. Global Comprehensive Metabolic Panel (CMP) Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Comprehensive Metabolic Panel (CMP) Testing Market

35. Comprehensive Metabolic Panel (CMP) Testing Market Future Outlook and Potential Analysis

  • 35.1 Comprehensive Metabolic Panel (CMP) Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Comprehensive Metabolic Panel (CMP) Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Comprehensive Metabolic Panel (CMP) Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer